ANORDNUNG

European patent · EP4234679 · In force

Register entry

Publication number
EP4234679
Application number
EP23178337
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 9, 2021
Published
Aug 30, 2023
Granted
Oct 8, 2025
Protection ends at the latest
Mar 8, 2041
Next annual fee due
Mar 31, 2027
IPC classes
C12M 1/00 (2006.01)
C12M 1/04 (2006.01)
C12M 1/12 (2006.01)
C12M 3/00 (2006.01)
Priority
GB 202003403 09.03.2020
GB 202019859 16.12.2020
Divided from
EP21713069
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 19, 2026

    Change

    Published in Swissreg on 19.08.2026

  2. Apr 10, 2026

    Next annual fee due on

    Next annual fee due on
    31.03.2026 → 31.03.2027

    Published in Swissreg on 10.04.2026

  3. Feb 19, 2026

    Agent entered

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 19.02.2026

  4. Oct 8, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 08.10.2025

Parties

Holder

Oribiotech Ltd

35 Beaufort Court Admirals Way South Quay Waterside, London E14 9XL, GB

Agent

HGF GmbH

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

Inventor

VERAITCH, Farlan

London, E14 9XL, GB

RAIMES, William

London, E14 9XL, GB

PALMER, Jason

Melbourn, SG8 6DP, GB

LITTEN, Neil

Melbourn, SG8 6DP, GB

SAWFORD, Michael

Melbourn, SG8 6DP, GB

GOWLER, Vincent

Melbourn, SG8 6DP, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.